LS
ANTH

Lupo Securities’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Lupo Securities’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1K Hold
11
– – 0.01% 114
2015
Q2 		$2K Buy
+11
New +$509 0.01% 97

Other funds holding ANTH

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
ProQuest Associates IV Naples, Florida $53M AUM 3.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return

Lupo Securities's ANTH Position: Q3 2015 in Review

Lupo Securities opened a new position in Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2015: 675 shares worth $33K. The stake represents 0.25% of the portfolio and ranks #39 among its holdings. This is a return to the name: Lupo Securities previously reported a position in ANTH as recently as Q1 2015.

Lupo Securities first reported a position in ANTH in Q4 2014 and has held it in 3 quarters since. 86 funds tracked by Wall St. Rank hold ANTH as of Q3 2015.

  • Lupo Securities held 675 shares of Anthera Pharmaceuticals, Inc. worth $33K as of Q3 2015.
  • Anthera Pharmaceuticals, Inc. was a new Lupo Securities position in Q3 2015.
  • Anthera Pharmaceuticals, Inc. made up 0.25% of Lupo Securities's portfolio in Q3 2015, its #39 holding.
  • Lupo Securities first reported a position in Anthera Pharmaceuticals, Inc. in Q4 2014 and has held it in 3 quarters since.
  • 86 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2015.

Based on Lupo Securities's 13F filing for Q3 2015, filed 13 Nov 2015.